Prognosis based on postoperative PSA levels and treatment in prostate cancer with lymph node involvement.

Tokiyoshi TanegashimaMasaki ShiotaTakahiro KimuraDai TakamatsuYoshiyuki MatsuiAkira YokomizoRyoichi SaitoShuichi MorizaneMakito MiyakeMasakazu TsutsumiYoshiyuki YamamotoKojiro TashiroRyotaro TomidaKohei EdamuraShintaro NaritaTakahiro YamaguchiTakashi KasaharaKohei HashimotoMasashi KatoTakayuki YoshinoShusuke AkamatsuAkihiro MatsukawaTomoyuki KanekoRyuji MatsumotoAkira JorakuManabu KatoToshihiro SaitoTakuma KatoShuichi TataranoShinichi SakamotoHidenori KannoNaoki TeradaNaotaka NishiyamaHiroshi KitamuraMasatoshi Etonull null

Published in: International journal of clinical oncology (2024)

This study provides valuable insights into stratifying patients based on postoperative PSA levels to tailor postoperative treatment strategies, potentially improving the prognosis of prostate cancer patients with LNI.

Keyphrases

prostate cancer
radical prostatectomy
patients undergoing
lymph node
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
squamous cell carcinoma
patient reported outcomes
radiation therapy
smoking cessation